What is going on with the trials??? I thought they would have announced the results already… Not a good sighn perhaps???
» What is going on with the trials??? I thought they would have announced
» the results already… Not a good sighn perhaps???
Just recently, according to clinicaltrials.gov, the the efficiency study of 2% topical neosh101 compared to 5% minoxidil has a status of completed, not ongoing like their dose-ranging study. I presume these two studies are the phase 2b mentioned in the press release 16 months ago. One thing that caught my attention was the dermal tolerability assessment in the secondary outcome measure that designated it as a safety issue. Does anyone know what this means? I saw that there is a dermatology workshop in Germany the 29th and 30th of this month and the vice president of clinical development at Neosil is giving a presentation on “End point measures in dermatology” maybe she’ll mention something? I just hope a published study comes out of the phase 2b trial.